Dorati, R.; DeTrizio, A.; Spalla, M.; Migliavacca, R.; Pagani, L.; Pisani, S.; Chiesa, E.; Conti, B.; Modena, T.; Genta, I.
Gentamicin Sulfate PEG-PLGA/PLGA-H Nanoparticles: Screening Design and Antimicrobial Effect Evaluation toward Clinic Bacterial Isolates. Nanomaterials 2018, 8, 37.
https://doi.org/10.3390/nano8010037
AMA Style
Dorati R, DeTrizio A, Spalla M, Migliavacca R, Pagani L, Pisani S, Chiesa E, Conti B, Modena T, Genta I.
Gentamicin Sulfate PEG-PLGA/PLGA-H Nanoparticles: Screening Design and Antimicrobial Effect Evaluation toward Clinic Bacterial Isolates. Nanomaterials. 2018; 8(1):37.
https://doi.org/10.3390/nano8010037
Chicago/Turabian Style
Dorati, Rossella, Antonella DeTrizio, Melissa Spalla, Roberta Migliavacca, Laura Pagani, Silvia Pisani, Enrica Chiesa, Bice Conti, Tiziana Modena, and Ida Genta.
2018. "Gentamicin Sulfate PEG-PLGA/PLGA-H Nanoparticles: Screening Design and Antimicrobial Effect Evaluation toward Clinic Bacterial Isolates" Nanomaterials 8, no. 1: 37.
https://doi.org/10.3390/nano8010037
APA Style
Dorati, R., DeTrizio, A., Spalla, M., Migliavacca, R., Pagani, L., Pisani, S., Chiesa, E., Conti, B., Modena, T., & Genta, I.
(2018). Gentamicin Sulfate PEG-PLGA/PLGA-H Nanoparticles: Screening Design and Antimicrobial Effect Evaluation toward Clinic Bacterial Isolates. Nanomaterials, 8(1), 37.
https://doi.org/10.3390/nano8010037